The effect of sodium balance on systemic arterial blood pressure and the renal response to intravenous infusion of prostaglandin A x (PGA t ) was studied in hypertensive subjects. PGA! (0.4 /ag/kg min~1) was infused for L hour in ten hypertensive subjects who were receiving a constant diet containing 40 mEq of sodium and 80 tnEq of potassium. During PGA t infusion a significant fall in both systolic and diastolic arterial bio ad pressure occurred. There was a significant rise in urine flow rate, renal plasma flow, and urine sodium excretion; plasma renin activity (PRA) rose slightly but not significantly. Eight of the ten subjects and one additional subject were then placed on furosemide (80 mg/day) for 1 week. In all subjects, a significant weight loss and a rise in midday PRA occurred with the administration of the diuretic. Systolic blood pressure fell, but diastolic pressure was unchanged. Following salt depletion with furosemide, PGAj infusion studies were repeated. PGAj then produced no significant change in systolic or diastolic blood pressure. Urine flow, renal plasma flow, and urine sodium excretion rose, but the degree of increase was markedly less than that observed prior to furosemide administration. In the salt-depleted subjects, a significant rise in PRA occurred during PGAj infusion. The results indicate that volume depletion diminishes the systemic and renal hemodynamic response to infused PGA! but enhances the PRA response. The increased PRA response during PGA! infusion observed in saltdepleted subjects might in part account for the blunted hemodynamic changes. Alternatively, recent evidence indicates that the enhanced production of endogenous vasodilating prostaglandins which occurs in the salt-depleted state might account for the diminished hemodynamic responses to exogenous PGA X .
cardiac rate and stroke volume leading to increased cardiac output (1) (2) (3) (4) . Increased renal blood flow alone occurs at low doses of the prostaglandins and is accompanied by diuresis and natriuresis (3) (4) (5) . It has been suggested (6) that natriuresis caused by prostaglandins is due solely to their vascular action; thus, they act like other renal vasodilators.
The profound effects of the prostaglandins on sodium excretion and renal perfusion suggest a possible interaction with the renin-angiotensin system. However, prior studies of the effect of prostaglandins on renin secretion have not revealed a uniform pattern. Direct infusion of PGEi and PGE 2 into the canine renal artery in concentrations sufficient to cause natriuresis and increased renal plasma flow without a change in systemic arterial blood pressure do not significantly alter renin secretion (7) . When much larger doses of PGEi are infused into the aorta above the kidneys in dogs, increased plasma renin activity accompanied 540 KRAKOFF, DE GUIA, VLACHAKIS, STRICKER, GOLDSTEIN by natriuresis and decreased arterial blood pressure without a significant alteration in renal plasma flow has been observed (8) . PGAi infusion in either normal human subjects or subjects with high blood pressure has produced variable and inconsistent alterations in plasma renin activity as assessed by bioassay techniques (1, 3, 4) .
Sodium and extracellular fluid volume metabolism are unquestionably important determinants of renal function and renin secretion by the kidney. The studies reported in this paper were designed, therefore, to assess the role of sodium balance in modifying the effect of PGAi on urine flow, sodium and potassium excretion, glomerular filtration rate, renal plasma flow, and renin secretion.
Methods
Eleven hypertensive patients were admitted to the Clinical Research Center, Mount Sinai Hospital, 2 weeks after all antihypertensive medication had been discontinued, and informed consent was obtained. On admission the patients were placed on constant diets containing 40 mEq of sodium and 80 mEq of potassium. Arterial blood pressure in the supine and the standing position was recorded twice daily and body weight was recorded each morning. A 24-hour urine sample for analysis of sodium, potassium, and creatinine was collected daily. Appropriate diagnostic studies including serum electrolytes, rapid sequence intravenous pyelography, and urine catecholamine metabolite determinations revealed no evidence of secondary hypertension in any patient.
After 5 days on the constant diet, plasma renin activity (PRA) was determined with specimens obtained at midday after 3 hours of ambulation. The next day patients remained supine in bed after awakening, and breakfast was withheld. Renal clearance studies were then carried out in the hydrated state for determination of urine flow, glomerular filtration rate (measured by inulin clearance), renal plasma flow (measured by para-aminohippuric acid [PAH] clearance), sodium excretion, and potassium excretion. After two to three control periods, a control specimen for determination of PRA was obtained. Then PGA^ (0.4 yttg/kg min-1 ) was infused intravenously with a constant-infusion peristaltic pump (Sigma motor) for 60 minutes during which two to three additional clearance periods were obtained. A second specimen for determination of PRA was obtained at the end of the PGA, infusion. Brachial arterial blood pressure was recorded by auscultation at 5-minute intervals throughout the clearance study.
Following the initial PGA X study while patients remained on the constant diet, furosemide (Lasix) (40 mg twice a day, orally) was administered for 6 days. On the sixth day of furosemide administration, midday 'Kindly supplied by Dr. Natoo Patel of the Upjohn Company, Kalamazoo, Michigan. specimens for determination of PRA were obtained. The next day renal clearance and PRA studies were repeated before and during infusion of PGAi (0.4 /ig/kg inkr 1 ) for 60 minutes. Seven additional PGAj infusion studies were carried out in hypertensive subjects who were receiving varying sodium intakes.
ANALYTICAL METHODS
Sodium and potassium were determined by flame photometry (Instrumentation Labs). Inulin and PAH were measured colorimetrically, and clearances were calculated by standard methods (9) . PRA was assessed by radioimmunoassay of angiotensin I generated during complete inhibition of plasma angiotensinase and converting enzyme (10) .
Results

Effect of PGA X Infusion on Arterial Blood
Pressure and Renal Function in Subjects on Constant Diet.-The effect of PGAi infusion on ten subjects studied on the constant diet is shown in Table 1 . In eight of ten subjects, systolic arterial blood pressure fell more than 10 mm Hg and diastolic arterial blood pressure fell 5 mm Hg or more during PGAi infusion. Urine flow rose in all subjects. The glomerular filtration rate rose by 10 ml/mn in six of ten subjects and fell in only one subject; in the other subjects, glomerular filtration rate was not significantly altered. Renal plasma flow rose in all but one subject. Although urine sodium excretion rose during PGAi infusion in all subjects, the degree of rise was quite variable as the increase in sodium excretion due to PGAi varied from 52 to 618 //.Eq/min. Urine potassium excretion rose during PGAi infusion in nine of ten subjects; however, the degree of increase in potassium excretion was also highly variable.
Effect of Furosemide on Body Weight, Arterial Blood Pressure and Midday Plasma Renin Activity.-Following the period of constant diet nine subjects were placed on furosemide (80 mg/day) for 6 days. Table 2 shows the body weight, the arterial blood pressure in the supine and standing positions, and the midday upright PRA values in subjects on the constant diet before and after 6 days of furosemide therapy. All subjects showed a weight loss varying from 0.7 to 2.5 kg. Arterial blood pressure fell more when the subjects were in the standing position than when they were in the supine position. PRA uniformly rose. Table 2 also shows the statistical comparisons for the changes in weight, arterial blood pressure, and PRA due to furosemide. There was a significant fall in weight and systolic blood pressure in both the supine and the standing position. Diastolic arterial blood Table 3 . PGAi infusion reduced systolic arterial blood pressure more than 10 mm Hg in only two subjects. Similarly, only two of nine subjects had a fall in diastolic arterial blood pressure of 5 mm Hg or more during PGA t infusion. Urine flow rose in all subjects during PGAi infusion. However, glomerular filtration rate showed little change. PGAi infusion caused a rise in renal plasma flow in all subjects in which it was determined. Urine sodium excretion also rose during PGAi infusion in all subjects studied, but the degree of rise was again highly variable. Urine potassium excretion rose in five of nine subjects during PGAi infusion and fell in three subjects.
Effect of PGA, Injzision i n Subjects on Conslant Diet
Effect of PGA t Infusion on Plasma Rerun Activity.-The level of PRA before and after PGAi infusion in subjects on the constant diet and in subjects after salt depletion due to furosemide is shown in Figure 1 . In subjects on the constant diet, PRA rose during PGAi infusion only when control PRA was greater than 0.5 ng/ml hour" 1 . Following furosemide administration, all subjects showed a significant rise in PRA during PGAi infusion. The relationship between the increase in PRA due to PGAx and the control level of PRA is shown in Figure 2 which includes all 19 studies of subjects on the constant diet before and after furosemide treatment and 7 additional studies of subjects ingesting diets of varying sodium content. The regression equation and the statistical analysis indicate a highly significant direct correlation between the control PRA and the increase in PRA due to PGA 2 infusion.
Comparison of PGAi Infusion in Subjects before and after Salt Depletion with Furosemide.-The contrasting effects of PGAi infusion on arterial blood pressure, renal function, and PRA in subjects ingesting the constant diet and after furosemideinduced salt depletion are shown in Table 4 . It is apparent that PGAi had a more profound hypotensive effect in subjects studied on the constant diet than it did in subjects studied after salt depletion. The increases in urine flow and renal plasma flow during PGAi infusion were significantly greater in subjects studied on the constant diet than it was in 543 subjects studied after furosemide administration. The mean increase in urine sodium excretion due to PGAi was 53% higher in subjects studied on the constant diet than it was in subjects studied after furosemide administration. However, the difference between these increases in sodium excretion was not statistically significant. The change in potassium excretion due to PGA X infusion did not appear substantially different in the two groups.
PGAi infusion did not produce a significant mean change in PRA in the subjects studied on the constant diet alone. In contrast, furosemide-treated subjects demonstrated a uniform, significant increase in PRA during PGAx infusion.
Discussion
In the present study the arterial blood pressure and the renal responses to PGAi infusion at a relatively low dose (0.4 /^g/kg min" 1 ) were Effect of PGA t infusion on plesma renin activity (PRA) in hypertensive subjects studied on constant sodium intake alone or after furosemide-induced sodium depletion. Each individual subject is represented by a single symbol. The statistical comparison of changes in PRA due to PCA t is given in evaluated in hypertensive subjects during two states of sodium balance. Initially, the effect of PGA a was studied in subjects maintained on a constant diet of moderately low sodium intake (40 mEq/day). On this regimen PGA X infusion caused a small but highly significant reduction in arterial blood pressure that agreed with the results of Lee et al. (11) . PRA 0 2 4 6 8 10 12
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Relationship between the increase in plasma renin activity (ii PRA) due to PGA t infusion and the control level of PRA (PRA C ). The equation for the straight line as calculated by a least-squares estimate is APRA -(1.11 ± 0.12) PRA C -0.005,-T = 0.872, P < 0.001.
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Urine flow, renal plasma flow, and sodium and potassium excretion were uniformly increased. PRA rose with PGA t only in those subjects who tended to have higher control PRA levels. However, in those subjects with lower control PRA levels (< 0.5 ng/ml hour 1 ) PGAi infusion had little effect on PRA.
Following sodium depletion with furosemide, PGAi infusion had no significant effect on arterial blood pressure. Although urine flow, sodium excretion, and renal plasma flow rose with PGAi infusion, the degree of increase in these measurements was less than that observed prior to furosemide administration. These data suggest that induced extracellular fluid volume depletion reduces the vasodilatory response to exogenously administered PGA!. The consistent rise in PRA observed in furosemide-treated subjects during PGAi infusion may partly account for the preservation of arterial blood pressure and the smaller increase in renal plasma flow. This finding is in agreement with recent studies indicating the importance of the renin-angiotensin system in the maintenance of arterial blood pressure in sodiumdepleted dogs(12).
The increase in PRA produced by PGAi was approximately 110% above the control PRA as indicated by the slope of the regression line in Figure 2 . This finding suggests that PGAi caused an increase in renal renin secretion, since in similar subjects renal venous renin activity averaged only 30% above peripheral PRA levels (13) .
Current theories on the control of renin release have emphasized either the macula densa of the distal renal tubule, a renal vascular receptor, or direct adrenergic mechanisms (14) (15) (16) (17) . In the present investigation PGAi produced a significant increase in PRA in the salt-depleted subjects in association with a modest natriuresis and a rise in renal plasma flow but caused no change in arterial blood pressure. It seems unlikely that the increased urine sodium excretion rate could account for the rise in PRA, since the natriuresis of prostaglandins is best related to decreased proximal tubular reabsorption of salt and water resulting in enhancement of distal tubular, i.e., macula densa, sodium supply (6, 7, 18) . This mechanism has been compared with saline infusion (6) which, like dietary salt loading, lowers PRA (19, 20) .
The rise in PRA that was produced by PGA X in the furosemide-treated subjects was accompanied by renal vasodilation and increased renal blood flow without a fall in perfusion pressure. Recent studies emphasize that the renal vascular receptor mechanism for control of renin release depends on a fall in renal perfusion pressure and is mediated by renal vasoconstriction (21, 22) .
It is possible that the rise in PRA observed during PGAx infusion was mediated through a baroreceptor adrenergic mechanism independent of renal vasoconstriction (16, 17, 22) . If an adrenergic mechanism accounted for the increase in PRA accompanying PGAi infusion in these studies, variable effects on PRA might be expected from higher doses of PGAi which might inhibit release of the sympathetic neurotransmitter (23) .
In one report it has been suggested that PGEi might have a direct renin-releasing effect in dogs. However, large doses of the lipid were used in this study producing hypotension and tachycardia (8) . Direct infusion of PGEi or PGE 2 in the canine renal artery in doses insufficient to cause systemic hemodynamic effects produced no effect on renin secretion (7) . Other renal vasodilators, papaverine or acetylcholine, have no direct effect on renin secretion when they are infused into the renal artery (22, 24) .
Prostaglandins PGA 2 , PGE 2 , and PGF 2a have been identified in extracts of the renal medulla from several species (25, 26) . A substance with PGE2like activity has been detected in canine renal venous blood (27) . The concentration of this substance in renal venous blood appears to increase after infusion of angiotensin II or norepinephrine into the renal artery (28). It has been observed in these experiments that the increase in PGE2 activity in renal venous blood is concurrent with the recovery of renal blood flow toward control levels despite continued infusion of vasoconstrictors. The participation of these prostaglandins in control of intrarenal circulation has been suggested. Recent studies indicate that prostaglandins of the A series are detectable in human plasma and may be increased in salt-depleted normal subjects (29). All of these observations indicate that in the saltdepleted state there might be increased production of the vasodilating prostaglandins mediated by enhanced action of the renin-angiotensin system. Elevated concentrations of endogenous prostaglandins of the E and A series might then blunt any further vasodilation by infused PGA X on the basis of simple dose-response relationships. Although this mechanism might explain the diminished hemodynamic responses to PGAi infusion observed in saltdepleted subjects, it does not account for the marked rise in PRA that occurred.
Whether the vasoactive prostaglandins function as circulating hormones or only as local mediators remains unclear. The changes in the arterial blood pressure and renal response to PGA! produced by diuretic-induced volume depletion which we have observed indicates that sodium and fluid balance may be important determinants of the cardiovascular action of these vasoactive lipids. 
